Mo1538 XMAB942, A POTENTIAL BEST-IN-CLASS, LONG-ACTING ANTI-TL1A ANTIBODY FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: PHASE 1 FINAL RESULTS

Gastroenterology 2026

View at publisher
Authors: Mark T. Osterman, Sudeepta Aggarwal, Jitendra Kanodia, Sahak Makaryan, Shelley S. Belouski, Nicole Rodriguez, Dipankar Chaudhuri, Sher Karki, Engie Salama, Ying Ding, Sophie Visonneau, Dane Leone
+2 more Bassil Dahiyat, John R. Desjarlais
DOI: 10.1016/s0016-5085(26)02977-x
Cited by: 1

Fields of Study & Subjects

Complement system in diseases Immune Response and Inflammation Diabetes and associated disorders

Publication details

Journal / source
Gastroenterology
Publisher
Elsevier BV
Volume
170
Issue
6
Pages
S–1177
Publication date
1 May 2026
Language
EN